<DOC>
	<DOCNO>NCT00821899</DOCNO>
	<brief_summary>This project evaluate effectiveness administration autologous bone marrow blood patient brittle type 1 diabetes mellitus restore insulin secretion . After mobilization hematopoietic progenitor ( G-CSF ) 3 day , 50 90 mL bone marrow blood obtain multifunction posterior iliac crest . The material obtain implanted pancreas magna pancreatic artery femoral catheterization .</brief_summary>
	<brief_title>Bone Marrow Autotransplantation Type 1 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<criteria>diabetes type 1 patient 18 50 year age 5 year evolution disease brittle diabetes ( HbA1c &gt; 8.5 % intensified treatment severe hypoglycemia episode history cancer hematologic alteration infectious disease positivity ( HIV , HCV etc . ) diabetic nephropathy cardiac failure liver disease autoimmune systemic disease allergy iodine contrast anesthesia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>diabetes type 1</keyword>
	<keyword>bone marrow transplantation</keyword>
</DOC>